
Dr Meral Kayikcioglu
@MeralKayikcoglu
Followers
5K
Following
20K
Media
962
Statuses
4K
Prof of Cardiology, Director of Lipid & CV prevention clinic Ege University, EAS #SoMe Ambassador, Assoc Editor #ArchivesofTSC
Turkey
Joined December 2017
3 hours to the EAS webinar .Dont miss today's webinar.Link to register :
us02web.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
Don’t miss! #EASLATAM Webinar is tomorrow! .Title: Cardiovascular Kidney & Metabolic Syndrome.🗓 Tuesday, August 26 (language:English) @society_eas .⏰ 18:00–19:00 CET.👉 Case-based presentation + live Q&A with.@MeralKayikcoglu (Chair) @FabianaRached @pabeda1.🔗 Free
0
1
9
Don’t miss! #EASLATAM Webinar is tomorrow! .Title: Cardiovascular Kidney & Metabolic Syndrome.🗓 Tuesday, August 26 (language:English) @society_eas .⏰ 18:00–19:00 CET.👉 Case-based presentation + live Q&A with.@MeralKayikcoglu (Chair) @FabianaRached @pabeda1.🔗 Free
0
5
17
RT @society_eas: Our Certificate is gaining more and more attention! Working in a lipid clinic means facing daily challenges in managing at….
0
12
0
Interesting findings; Sex-specific adiposity drives CV ageing. In 21,241 UK Biobank participants, visceral adipose tissue, muscle fat infiltration, & liver fat increased CV age-δ in both sexes; .android fat added risk in males, while .gynoid fat was protective—especially.
Patterns of body fat are associated with both protective and harmful changes in cardiovascular ageing. #fat #obesity #cardiotwitter, @ESC_Journals, @escardio
1
3
14
RT @LaleTokgozoglu: Out recent publication from the ESC roundtable on nucleic acid based therapies @TKDsosyal @MeralKayikcoglu @ProfKausikR….
academic.oup.com
Abstract. Cardiovascular (CV) diseases continue to cause substantial morbidity and mortality. Risk factors are inadequately controlled, compliance with med
0
8
0
RT @BNordestgaard: ASCVD risk reductions are expected for remnant cholesterol lowering drugs .- if intervention trials with novel remnant….
0
15
0
RT @markinho_gc: 🔰La Lp(a) en la prevención primaria de enfermedades cardiovasculares es una herramienta práctica hoy en día. ✅Esta revisi….
0
22
0
First #EASLATAM Webinar of 2025 is coming up soon! .Title: Cardiovascular Kidney & Metabolic Syndrome .Tuesday, August 26 at CET. Don't miss this🩺 Case-based presentation + live Q&A with @merakayikcoglu @FabianaRached & @pabeda1 .free registration link:
0
3
6
RT @drpablocorral: 👉Cholesterol Crystals: Not Just a Marker — A Causal Trigger of Vascular Inflammation. ☝️A growing body of evidence highl….
0
24
0
RT @LaleTokgozoglu: #aspc25 was an inspirational meeting. Great to Connect with friends in Boston @ProfKausikRay @MeralKayikcoglu @DrMartha….
0
7
0